The history of Viagra, and its parent company copyright, presents a challenging case study for investors. Originally a blockbuster drug, yielding billions in income, its intellectual property lapse created a flood of lower-priced alternatives , significantly impacting its position . While certain firms may seek to capitalize on similar conditions ,